News for 'Big Pharma'

India business to put a spring in pharma's step

India business to put a spring in pharma's step

Rediff.com26 Apr 2023

Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.

Modi 3.0's Plans For Ayushman Bharat

Modi 3.0's Plans For Ayushman Bharat

Rediff.com12 Jun 2024

The Centre is considering a proposal on increasing coverage under the Ayushman Bharat scheme to Rs 10 lakh from the current Rs 5 lakh.

Sensex jumps 603 points; ICICI Bank climbs 3%

Sensex jumps 603 points; ICICI Bank climbs 3%

Rediff.com28 Oct 2024

From the 30 Sensex pack, ICICI Bank climbed 3 per cent after the private sector lender posted a 14.5 per cent growth in standalone profit to Rs 11,746 crore for the second quarter ended September 2024. JSW Steel, Mahindra & Mahindra, Adani Ports, Tata Steel, Sun Pharma, Hindustan Unilever, Tata Motors and State Bank of India were the other big gainers from the pack.

Markets cheer Trump's triumph; Sensex soars 901 points

Markets cheer Trump's triumph; Sensex soars 901 points

Rediff.com6 Nov 2024

From the 30-share Sensex pack, Tata Consultancy Services and Infosys jumped over 4 per cent each. HCL Technologies, Tech Mahindra, Adani Ports, Larsen & Toubro, Maruti and Reliance Industries were also among big gainers. Titan, IndusInd Bank, Hindustan Unilever, Axis Bank and HDFC Bank were the laggards.

Sensex tanks 663 points; IndusInd Bank plunged over 18%

Sensex tanks 663 points; IndusInd Bank plunged over 18%

Rediff.com25 Oct 2024

From the 30 Sensex pack, IndusInd Bank plunged over 18.50 per cent after the firm reported a 40 per cent decline in September quarter net profit at Rs 1,331 crore, pulled down by concerns over its asset quality. Mahindra & Mahindra, Larsen & Toubro, NTPC, Adani Ports, Tata Steel, Maruti, Bajaj Finance and Titan were also among the laggards.

Indian pharma cos: Discoverers or copy cats?

Indian pharma cos: Discoverers or copy cats?

Rediff.com28 Mar 2008

India's pharma companies are moving beyond generics to set their sights on the research and development of new drugs, but the risks are many

Investors lose Rs 7.15 lakh cr as markets slump

Investors lose Rs 7.15 lakh cr as markets slump

Rediff.com25 Oct 2024

Investors' wealth eroded by a whopping Rs 7.15 lakh crore during the morning trade on Friday as equity markets tumbled, driven by sharp fall in IndusInd Bank shares and unabated foreign fund outflows. The BSE Sensex tanked 708.69 points to 79,356.47 and the NSE Nifty plunged 286.35 points to 24,113.05. Tracking the weak trend in equities, the market capitalisation of BSE-listed firms tumbled Rs 715,739.19 crore to Rs 4,36,63,565.73 crore ($5.19 trillion) during the morning trade.

What You Don't Know About Ambani, Adani Wealth

What You Don't Know About Ambani, Adani Wealth

Rediff.com21 Jan 2025

Ambani and Adani account for a fifth of the net worth of all billionaire promoters in the country and half the combined net worth of the top 10.

Markets recovery makes investors richer by Rs 4.21 lakh cr

Markets recovery makes investors richer by Rs 4.21 lakh cr

Rediff.com28 Oct 2024

Investors' wealth on Monday surged Rs 4.21 lakh crore as markets bounced back after five days of fall. The BSE Sensex jumped 602.75 points or 0.76 per cent to settle at 80,005.04. During the day, it surged 1,137.52 points or 1.43 per cent to 80,539.81.

'Second-gen promoters more open to selling out'

'Second-gen promoters more open to selling out'

Rediff.com6 Jun 2024

'There is not any negative connotation associated with it.'

Trade generics growth to dent value expansion of domestic drug market

Trade generics growth to dent value expansion of domestic drug market

Rediff.com2 Jan 2024

Rising penetration of trade generic medicines is eating into the value growth of the domestic pharmaceutical market, showed a recent analysis. According to a Kotak Institutional Equities analysis, 70-110 basis points (bps) annual dent is expected from trade generics and Jan Aushadhi on Indian Pharma Market (IPM) growth at least until FY27-28 (see chart). Trade generic medicines are those that are not pushed into the market through doctor promotions.

'Power shifts to chemists instead of doctors'

'Power shifts to chemists instead of doctors'

Rediff.com22 Aug 2023

'Whichever company offers better incentives, the chemist would prefer it.'

India's Big Guns Firing On Capex Front

India's Big Guns Firing On Capex Front

Rediff.com13 Feb 2024

'Interim Budget has ignited the entrepreneurial spirit.'

Sensex back above 81K; Nifty surges 429 points

Sensex back above 81K; Nifty surges 429 points

Rediff.com26 Jul 2024

Bharti Airtel was the biggest gainer, rising by over 4.51 per cent. Adani Ports, Sun Pharma, Tata Steel, HCL Technologies, Infosys, JSW Steel and Mahindra & Mahindra were the other big gainers.

Sensex, Nifty hit new all-time closing highs; Maruti top gainer

Sensex, Nifty hit new all-time closing highs; Maruti top gainer

Rediff.com9 Jul 2024

Mahindra & Mahindra, Titan, Sun Pharma, ITC, Nestle and Tata Motors were the other big gainers. Reliance Industries, Kotak Mahindra Bank, Bajaj Finance and JSW Steel were among the laggards.

Pharma stocks make a comeback as Covid cases surge

Pharma stocks make a comeback as Covid cases surge

Rediff.com20 Apr 2021

However, experts caution that investors should not expect the big returns they got from the sector between March and September 2020.

2024's 10 Best Web Series

2024's 10 Best Web Series

Rediff.com9 Dec 2024

The year was rich in content as far as Web series were concerned.

Why Vettaiyan May Become A Blockbuster

Why Vettaiyan May Become A Blockbuster

Rediff.com8 Oct 2024

'The combination of star power, compelling storytelling, and action-packed drama promises to set the box office ablaze and kickstart the new quarter on a spectacular high note.'

'Gave you my best': Biden passes the baton to Kamala

'Gave you my best': Biden passes the baton to Kamala

Rediff.com20 Aug 2024

Harris, 59, is scheduled to formally accept the Democratic Party's presidential nomination on Thursday to take on Republican rival Donald Trump, 78, in the November 5 election.

Almost fell asleep: Biden on debate debacle against Trump

Almost fell asleep: Biden on debate debacle against Trump

Rediff.com3 Jul 2024

The White House acknowledged that Biden did not have a "great (debate) night,", but asserted that he knew how to get things done and is ready to run the country for the next four years.

Markets fall on selling in banking shares, STT hike

Markets fall on selling in banking shares, STT hike

Rediff.com24 Jul 2024

Benchmark BSE Sensex declined for the fourth day in a row on Wednesday due to selling in financial and banking shares and the government's move to hike securities transaction tax and short term capital gains tax. The 30-share BSE Sensex declined 280.16 points or 0.35 per cent to settle at 80,148.88 with 19 of its components closing lower and 11 with gains. During the day, it tumbled 678.53 points or 0.84 per cent to 79,750.51.

Goodbye Skipper!

Goodbye Skipper!

Rediff.com29 Nov 2024

'He asserted in his usual jovial style that he was not an MBA like his audience at IIM-Ahmedabad but perhaps had an even better business degree: MBB'. 'He went on to explain to his perplexed, blue chip B-School audience that MBB stood for "Marwadi by birth"!' Shivanand Kanavi salutes Shashi Ruia, co-founder of the Essar group who passed into the ages on November 25, 2024 in Mumbai.

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Indemnity demands from pharma firms hit foreign Covid vaccine buy: Mandaviya

Rediff.com25 Jun 2023

He also said that it was wrong to suggest that India stopped foreign made vaccines like that made by Moderna and Pfizer from coming to India.

Electoral bonds: Cong says firms donating to BJP got big projects

Electoral bonds: Cong says firms donating to BJP got big projects

Rediff.com15 Mar 2024

The Congress on Friday alleged that the electoral bonds data has exposed 'corrupt tactics' of the Bharatiya Janata Party such as quid pro quo, seeking donations for the company's protection, kickbacks and money laundering through shell companies.

Quality Lapses Shut Down Drug Makers

Quality Lapses Shut Down Drug Makers

Rediff.com28 Jun 2024

Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.

PE firms bet big on Indian pharma

PE firms bet big on Indian pharma

Rediff.com8 Feb 2008

Deals indicate growing interest of private equity firms in India's pharma and healthcare segments.

Exports dip 1.2% in Jul; trade deficit widens to $23.5 bn

Exports dip 1.2% in Jul; trade deficit widens to $23.5 bn

Rediff.com14 Aug 2024

After remaining in the positive zone for three months, India's exports contracted 1.2 per cent to $33.98 billion in July, while the trade deficit widened to $23.5 billion.

MSCI Index inclusion likely to spur big churn for domestic stocks

MSCI Index inclusion likely to spur big churn for domestic stocks

Rediff.com22 Nov 2023

IndusInd Bank, Suzlon, and Paytm will remain under focus, as the stocks are pegged to get added to the MSCI global standard index. These stocks, along with six others, are seen attracting cumulative inflows of nearly $2 billion from passive funds tracking MSCI indices. Persistent Systems, APL Apollo, Polycab, Macrotech Developers, Tata Motors DVR, and Tata Communication are the other six stocks that will be added to the MSCI index, shows an analysis done by Nuvama Alternative & Quantitative Research.

Stock markets edge down on STT, LTCG hike

Stock markets edge down on STT, LTCG hike

Rediff.com23 Jul 2024

Adani Ports, NTPC, Infosys, Hindustan Unilever, HCL Technologies and Sun Pharma were among the other big gainers. However, Larsen & Toubro, Bajaj Finance, State Bank of India, Axis Bank and HDFC Bank were amonh the major laggards.

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

Modi @ 3.0: Sensex races past 76K, Nifty rises 733 points

Modi @ 3.0: Sensex races past 76K, Nifty rises 733 points

Rediff.com3 Jun 2024

Larsen & Toubro, Axis Bank, Reliance Industries, UltraTech Cement, Mahindra & Mahindra, IndusInd Bank, ICICI Bank and Tata Steel were the other big gainers. Sun Pharma, HCL Technologies, Asian Paints, Nestle and Infosys were the laggards.

Investors richer by Rs 13.78 lakh cr in exit poll rally

Investors richer by Rs 13.78 lakh cr in exit poll rally

Rediff.com3 Jun 2024

Investors' wealth jumped Rs 13.78 lakh crore on Monday as the benchmark equity index Sensex hit its lifetime high after exit polls predicted a massive win for the BJP-led NDA in the Lok Sabha polls. The 30-share BSE Sensex jumped 2,777.58 points or 3.75 per cent to hit a record peak of 76,738.89 in early trade. The benchmark finally ended at 76,468.78, registering a sharp rally of 2,507.47 points or 3.39 per cent.

He inspired Indian pharma to dream big and deliver

He inspired Indian pharma to dream big and deliver

Rediff.com16 Mar 2013

Dilip S Shanghvi reminisces about Anji Reddy.

Big leap for Sun Pharma, Sunshine for Ranbaxy

Big leap for Sun Pharma, Sunshine for Ranbaxy

Rediff.com8 Apr 2014

Ranbaxy's troubled plants in India could see a turnaround as Sun Pharma has experience in doing so.

Gujarat pharma hub hit by near-zero exports

Gujarat pharma hub hit by near-zero exports

Rediff.com15 Apr 2020

With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly have any work now. At a petrol pump on the deserted Bavla-Changodar highway near Ahmedabad in Gujarat, several trucks and buses are neatly parked in a row.

Consumer goods firms likely to see an upswing after year of lull

Consumer goods firms likely to see an upswing after year of lull

Rediff.com24 Jul 2024

The Budget proposals are expected to boost the fortunes of consumer goods and fast-moving consumer goods companies, which have been struggling with poor consumer demand for more than a year. The Budget announcements, such as the increase in standard deduction by Rs 25,000 for income-tax payers and slab revisions, will put more money in their hands, boosting consumer demand. Private consumption is also likely to benefit from a new scheme to offer internships to 10 million youths in the country's top 500 companies.

How start-ups are shaking up offline pharma business

How start-ups are shaking up offline pharma business

Rediff.com3 Aug 2022

Bulk of the medicine sales in the $22-24 billion domestic pharma market happens through offline retail chemists. With the entry of online pharmacies, this space has started to witness a shake-up. Sample this: Dawaa Dost, a Rajasthan based digital health start-up, generates medicine orders from 'kirana' stores and women self-help groups (SHGs) that operate in villages, and then service these orders through its affiliated network of pharmacies. Biddano, another health-tech start-up, has a platform that acts as an aggregator for neighbourhood chemist shops.

Stock Market: Which Sectors Delivered?

Stock Market: Which Sectors Delivered?

Rediff.com12 Jan 2024

The biggest bounce is in the realty sector, where the industry index jumped 80%. There's been a turnaround also in automobiles and ancillaries (up 45%). The pharma and health care indices have a welcome return of roughly 35%.